drugset / Trial / NCT00404755

Dichotic Listening as a Predictor of Medication Response in Depression

NCT00404755

Phase 4 Completed 17 enrolled New York State Psychiatric Institute
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will recruit 100 depressed patients to test whether the previous finding of an association between treatment response (with treatment groups including placebo, imipramine, and fluoxetine) and preferences of hemispheric laterality in perceptual processing are also found with a different type of commonly used anti-depressant, bupropion.

Timeline

Start
2006-07
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 450 mg
Subject Escitalopram Small molecule 40 mg
Subject Imipramine Small molecule 300 mg